Log In
BCIQ
Print this Print this
 

Boniva IV, ibandronate (CT-064, RG484)

Also known as: Boniva, Bonviva

  Manage Alerts
Collapse Summary General Information
Company Roche
DescriptionIV bisphosphonate that inhibits osteoclast-mediated bone resorption
Molecular Target Not available
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationOsteoporosis
Indication DetailsTreat osteoporosis
Regulatory Designation
PartnerChugai Pharmaceutical Co. Ltd.;
GlaxoSmithKline plc;
Taisho Pharmaceutical Holdings Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

06/20/2011

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today